Rocket Lab's core risk is sequence, not demand.
Electron and Space Systems show real traction, but the equity still hinges on three hard conversions:
Neutron from program to product,
Iridium from deal to recurring mix upgrade, and higher cadence from
backlog proof to durable margins. With valuation already rich, even moderate execution slips can matter more than strong headline growth.